Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$751M |
| 2 |
Home Depot
HD
|
+$408M |
| 3 |
Altria Group
MO
|
+$378M |
| 4 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$298M |
| 5 |
Texas Instruments
TXN
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$868M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$819M |
| 3 |
Amgen
AMGN
|
+$552M |
| 4 |
Merck
MRK
|
+$482M |
| 5 |
Cisco
CSCO
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.87% |
| 2 | Financials | 11.48% |
| 3 | Healthcare | 9.94% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
MediciNova
MNOV
$65M
| $93.7K | ﹤0.01% |
71,506
| – | – |
|
3402
One Stop Systems
OSS
$317M
| $92.7K | ﹤0.01% |
12,911
| – | – |
|
3403
Sagimet Biosciences
SGMT
$588M
| $88.8K | ﹤0.01% |
15,000
| – | – |
|
3404
Intellicheck
IDN
$76.3M
| $86.6K | ﹤0.01% |
12,962
| – | – |
|
|
ARAI
3405
Arrive AI Inc
ARAI
$14M
| $86.3K | ﹤0.01% |
32,802
-19
| -0.1% | -$79 |
|
3406
Empire Petroleum
EP
$105M
| $85K | ﹤0.01% |
27,967
-25,664
| -48% | -$86.2K |
|
3407
Ring Energy
REI
$357M
| $84.5K | ﹤0.01% |
97,091
-15
| -0% | -$14 |
|
3408
INmune Bio
INMB
$57.7M
| $78.4K | ﹤0.01% |
50,252
+8,427
| +20% | +$15K |
|
3409
Shattuck Labs
STTK
$686M
| $76.2K | ﹤0.01% |
20,881
| – | – |
|
|
SLSN
3410
Solesence Inc
SLSN
$72M
| $75.6K | ﹤0.01% |
47,387
| – | – |
|
3411
Amplify Energy
AMPY
$186M
| $74.9K | ﹤0.01% |
16,380
+4
| +0% | +$20 |
|
3412
Myomo
MYO
$59.8M
| $74.2K | ﹤0.01% |
81,566
| – | – |
|
3413
Smart Sand
SND
$200M
| $69.8K | ﹤0.01% |
17,439
| – | – |
|
3414
Spero Therapeutics
SPRO
$71.2M
| $66.6K | ﹤0.01% |
28,565
| – | – |
|
|
TEAD
3415
Teads Holding Co
TEAD
$65.6M
| $63.6K | ﹤0.01% |
90,382
-10,202
| -10% | -$10.8K |
|
|
HURA
3416
TuHURA Biosciences
HURA
$146M
| $62K | ﹤0.01% |
81,920
+2,888
| +4% | +$5.53K |
|
3417
Blink Charging
BLNK
$85.5M
| $59.6K | ﹤0.01% |
+89,324
| New | +$129K |
|
|
TGEN
3418
Tecogen Inc
TGEN
$121M
| $59.3K | ﹤0.01% |
12,000
| – | – |
|
3419
Coya Therapeutics
COYA
$113M
| $58K | ﹤0.01% |
10,000
| – | – |
|
|
GOCO
3420
DELISTED
GoHealth
GOCO
| $56.9K | ﹤0.01% |
26,448
+14,388
| +119% | +$49.1K |
|
3421
Neonode
NEON
$16.4M
| $53.6K | ﹤0.01% |
30,796
| – | – |
|
3422
Research Solutions
RSSS
$70.9M
| $53.1K | ﹤0.01% |
18,069
| – | – |
|
3423
flyExclusive
FLYX
$68.4M
| $52.6K | ﹤0.01% |
12,799
| – | – |
|
|
FLNA
3424
Filana Therapeutics
FLNA
$46.9M
| $51.5K | ﹤0.01% |
25,998
-51
| -0.2% | -$163 |
|
3425
Wrap Technologies
WRAP
$104M
| $51.2K | ﹤0.01% |
21,515
| – | – |
|
Similar funds
Charles Schwab's Q4 2025 Portfolio in Review
As of Q4 2025, Charles Schwab held 3,523 positions worth $644B, up 2.7% from $626B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 3.8%. Charles Schwab opened 68 new positions and exited 67, leaving the 3,523-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2025 buy was Qnity Electronics Inc: 1,489,517 shares worth $122M.
- Charles Schwab added most to Meta Platforms (Facebook) in Q4 2025, an estimated $751M increase.
- Charles Schwab's biggest Q4 2025 reduction was Broadcom, cutting an estimated $868M.
- Charles Schwab fully exited Vanguard S&P 500 ETF in Q4 2025, selling an estimated $819M.
- Charles Schwab's ten largest holdings make up 25% of its $644B portfolio in Q4 2025.
- Charles Schwab opened 68 new positions and closed 67 in Q4 2025.
- Charles Schwab's portfolio value rose 2.7% quarter-over-quarter to $644B.
Based on Charles Schwab's 13F filing for Q4 2025, filed 13 Feb 2026.